Long
ACT/BMO gaps up in higher volume when market is down
Keep an eye on the spread of ACT/BMO, which broke out on Friday when the general market moved in the other direction (well this is a market neutral strategy).
It gapped up, finishing at the high of it's daily range, in higher volume and on a Friday, all of which are significant.
Actavis is a well held pharmaceutical stock which has good strength relative to the market and is due to post earnings on 18/2/2015 with the last quarter showing a 53% increase in EPS and an increase in like for like quarterly sales of 83%.
The Bank of Montreal Quebec finished down 4.87% on Friday in higher volume. It is also due to report earnings this month (around 25th February) although its own EPS last quarter was down 99% although it showed an increase in like for like quarterly sales of 3%.
It gapped up, finishing at the high of it's daily range, in higher volume and on a Friday, all of which are significant.
Actavis is a well held pharmaceutical stock which has good strength relative to the market and is due to post earnings on 18/2/2015 with the last quarter showing a 53% increase in EPS and an increase in like for like quarterly sales of 83%.
The Bank of Montreal Quebec finished down 4.87% on Friday in higher volume. It is also due to report earnings this month (around 25th February) although its own EPS last quarter was down 99% although it showed an increase in like for like quarterly sales of 3%.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.